S. E. Wolkenberg
Papers
1
Total Citations
26
H-Index
1
About
S. E. Wolkenberg is a leading medicinal chemist whose work bridges the gap between cutting-edge synthetic methodology and practical drug discovery. Their research focuses on developing novel cross-coupling strategies, particularly deoxygenative C(sp²)-C(sp³) bond formations, to enable rapid parallel medicinal chemistry. A key contribution is the automation of these transformations, allowing alcohols—among the most abundant and diverse building blocks—to serve as alkyl precursors in metallaphotoredox reactions. This innovation addresses a critical bottleneck in pharmaceutical synthesis, expanding the chemical space accessible for lead optimization. Their most cited work (2023, 26 citations) demonstrates how this approach streamlines the production of drug-like molecules, reducing reliance on traditional organometallic reagents. Wolkenberg’s impact lies in translating complex photoredox chemistry into robust, high-throughput protocols that accelerate the discovery of new therapeutics. Their achievements have been recognized through collaborations with major pharmaceutical companies and presentations at international symposia, cementing their reputation as a pioneer in automated medicinal chemistry.
Research Focus
Key Achievements
Top Papers
- 1